Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rowbotham

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Neurology|December 11, 2002
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic painM S Wallace, M C Rowbotham, N P Katz, et al.
European Journal of Pain (London, England)|January 23, 2013
Neuropathic pain needs systematic classificationN B Finnerup, J Scholz, N Attal, et al.
Pain|May 17, 2014
Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION studyJohn T Farrar, Andrea B Troxel, Kevin Haynes, et al.
Journal of Clinical Epidemiology|January 28, 2017
Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic reviewJennifer S Gewandter, Rachel A Kitt, Matthew R Hunsinger, et al.
Pain|September 19, 2012
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic reviewShannon M Smith, Daniel R Chang, Anthony Pereira, et al.
Pain|December 15, 2010
Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTIONRobert H Dworkin, Dennis C Turk, Nathaniel P Katz, et al.
The Journal of Pain|August 16, 2016
Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic ReviewMark R Williams, Andrew McKeown, Zachary Pressman, et al.
Pain|October 7, 2014
Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendationsJennifer S Gewandter, Michael P McDermott, Andrew McKeown, et al.
The Journal of Pain|December 3, 2014
Data interpretation in analgesic clinical trials with statistically nonsignificant primary analyses: an ACTTION systematic reviewJennifer S Gewandter, Andrew McKeown, Michael P McDermott, et al.
Pain|April 23, 2013
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Anthony T Wang, Nathaniel P Katz, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Neurology|December 11, 2002
A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic painM S Wallace, M C Rowbotham, N P Katz, et al.
European Journal of Pain (London, England)|January 23, 2013
Neuropathic pain needs systematic classificationN B Finnerup, J Scholz, N Attal, et al.
Pain|May 17, 2014
Effect of variability in the 7-day baseline pain diary on the assay sensitivity of neuropathic pain randomized clinical trials: an ACTTION studyJohn T Farrar, Andrea B Troxel, Kevin Haynes, et al.
Journal of Clinical Epidemiology|January 28, 2017
Reporting of data monitoring boards in publications of randomized clinical trials is often deficient: ACTTION systematic reviewJennifer S Gewandter, Rachel A Kitt, Matthew R Hunsinger, et al.
Pain|September 19, 2012
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: an ACTTION systematic reviewShannon M Smith, Daniel R Chang, Anthony Pereira, et al.
Pain|December 15, 2010
Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTIONRobert H Dworkin, Dennis C Turk, Nathaniel P Katz, et al.
The Journal of Pain|August 16, 2016
Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic ReviewMark R Williams, Andrew McKeown, Zachary Pressman, et al.
Pain|October 7, 2014
Reporting of intention-to-treat analyses in recent analgesic clinical trials: ACTTION systematic review and recommendationsJennifer S Gewandter, Michael P McDermott, Andrew McKeown, et al.
The Journal of Pain|December 3, 2014
Data interpretation in analgesic clinical trials with statistically nonsignificant primary analyses: an ACTTION systematic reviewJennifer S Gewandter, Andrew McKeown, Michael P McDermott, et al.
Pain|April 23, 2013
Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendationsShannon M Smith, Anthony T Wang, Nathaniel P Katz, et al.
Pageof 15